SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-146418
Filing Date
2022-05-10
Accepted
2022-05-10 17:03:29
Documents
6
Effectiveness Date
2022-05-10

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ON FORM S-8 d310603ds8.htm S-8 50522
2 EX-5.1 d310603dex51.htm EX-5.1 13680
3 EX-23.2 d310603dex232.htm EX-23.2 1551
4 EX-FILING FEES d310603dexfilingfees.htm EX-FILING FEES 20724
5 GRAPHIC g310603dsp2.jpg GRAPHIC 11010
6 GRAPHIC g310603dsp3.jpg GRAPHIC 9875
  Complete submission text file 0001193125-22-146418.txt   105730
Mailing Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-264846 | Film No.: 22910856
SIC: 2836 Biological Products, (No Diagnostic Substances)